SCHEMBL6997

SCHEMBL6997

O=C(O)[C@@H]1CCCN1S(=O)(=O)c1ccccc1

nearest known ligand 0.82

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.65
HTT P42858 1/20 0.65
MMP2 P08253 2/20 0.62
MMP9 P14780 2/20 0.62
KDM4E B2RXH2 1/20 0.59
HSD17B10 Q99714 1/20 0.59
FKBP1A P62942 2/20 0.59
MMP8 P22894 1/20 0.57
MMP12 P39900 1/20 0.57
MMP13 P45452 1/20 0.57
POLB P06746 1/20 0.57
LMNA P02545 3/20 0.55
MAPT P10636 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
GAA P10253 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23519421 1.00 ALDH1A1 (0.65) ALDH1A1HTTMMP2MMP9KDM4E
SCHEMBL6996 1.00 ALDH1A1 (0.65) ALDH1A1HTTMMP2MMP9KDM4E
Water SCHEMBL28790504 0.98 ALDH1A1 (0.63) ALDH1A1HTTMMP2MMP9KDM4E
SCHEMBL2977278 0.95 ALDH1A1 (0.72) ALDH1A1HTTMMP2MMP9HSD17B10
SCHEMBL1385016 0.95 ALDH1A1 (0.72) ALDH1A1HTTMMP2MMP9HSD17B10
SCHEMBL5702097 0.92 ALDH1A1 (0.58) ALDH1A1HTTMMP2MMP9KDM4E
SCHEMBL5702286 0.92 ALDH1A1 (0.58) ALDH1A1HTTMMP2MMP9KDM4E
SCHEMBL21519741 0.92 ALDH1A1 (0.58) ALDH1A1HTTMMP2MMP9KDM4E
SCHEMBL1750430 0.91 MMP2 (0.76) ALDH1A1HTTMMP2MMP9KDM4E
SCHEMBL4653160 0.91 MMP2 (0.76) ALDH1A1HTTMMP2MMP9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1510 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8614201-B2 Heterocyclic amides as modulators of TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2013-12-24 US claimed
WO-2010141805-A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 WO claimed
US-7410995-B1 N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders GPI NIL HOLDINGS INC. (US) 2008-08-12 US claimed
EP-0944618-B1 NOVEL N-BENZENESULPHONYL-L-PROLINE DERIVATIVES, METHOD FOR PREPARING AND THERAPEUTIC USE FOURNIER IND & SANTE (FR) 2003-09-24 EP claimed
EP-0991650-B1 NOVEL N-BENZENESULPHONYL-L-PROLINE COMPOUNDS, PREPARATION METHOD AND USE IN THERAPY FOURNIER IND & SANTE (FR) 2003-09-10 EP claimed
US-20020010205-A1 N-linked sulfone of heterocyclic thioester hair growth compositions and uses GPI NIL HOLDINGS, INC. 2002-01-24 US claimed
EP-1149099-A2 IMIDAZO[4,5-C]-PYRIDINE-4-ON-DERIVATIVES MERCK PATENT GmbH (DE) 2001-10-31 EP claimed
EP-0925295-B1 N-BENZENESULPHONYL-L-PROLINE DERIVATIVES AS B2 RECEPTOR ANTAGONISTS OF THE BRADYKININ FOURNIER IND & SANTE (FR) 2001-10-04 EP claimed
EP-1105126-A2 SULFONAMIDES OF N-CONTAINING HETEROCYCLIC THIOESTERS FOR VISION AND MEMORY DISORDERS GPI NIL Holdings, Inc. (US) 2001-06-13 EP claimed
EP-1085854-A1 N-LINKED SULFONAMIDE OF HETEROCYCLIC THIOESTER HAIR GROWTH COMPOUNDS AND USES GPI NIL Holdings, Inc. (US) 2001-03-28 EP claimed
US-6063791-A N-benzenesulfonyl-L-proline derivatives, method for preparing and therapeutic use FOURNIER INDUSTRIE ET SANTE (FR) 2000-05-16 US claimed
EP-0991650-A1 NOVEL N-BENZENESULPHONYL-L-PROLINE COMPOUNDS, PREPARATION METHOD AND USE IN THERAPY FOURNIER INDUSTRIE ET SANTE (FR) 2000-04-12 EP claimed
WO-2000009107-A2 SULFONAMIDES OF N-CONTAINING HETEROCYCLIC THIOESTERS FOR VISION AND MEMORY DISORDERS GPI NIL HOLDINGS, INC. (US) 2000-02-24 WO claimed
WO-1999062489-A1 N-LINKED SULFONAMIDE OF HETEROCYCLIC THIOESTER HAIR GROWTH COMPOUNDS AND USES GPI NIL HOLDINGS, INC. (US) 1999-12-09 WO claimed
EP-0944618-A1 NOVEL N-BENZENESULPHONYL-L-PROLINE DERIVATIVES, METHOD FOR PREPARING AND THERAPEUTIC USE FOURNIER INDUSTRIE ET SANTE (FR) 1999-09-29 EP claimed
EP-0925295-A1 N-BENZENESULPHONYL-L-PROLINE DERIVATIVES AS BRADYKININ B2 AGONISTS FOURNIER INDUSTRIE ET SANTE (FR) 1999-06-30 EP claimed
US-5874449-A INHIBITORS OF IMMUNOPHILIN GPI NIL HOLDINGS, INC. (US) 1999-02-23 US claimed
WO-1999000387-A1 NOVEL N-BENZENESULPHONYL-L-PROLINE COMPOUNDS, PREPARATION METHOD AND USE IN THERAPY FOURNIER INDUSTRIE ET SANTE (FR) 1999-01-07 WO claimed
WO-1998024783-A1 NOVEL N-BENZENESULPHONYL-L-PROLINE DERIVATIVES, METHOD FOR PREPARING AND THERAPEUTIC USE FOURNIER INDUSTRIE ET SANTE (FR) 1998-06-11 WO claimed
WO-1998003503-A1 N-BENZENESULPHONYL-L-PROLINE DERIVATIVES AS BRADYKININ B2 AGONISTS FOURNIER INDUSTRIE ET SANTE (FR) 1998-01-29 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010205-A1 N-linked sulfone of heterocyclic thioester hair growth compositions and uses ACOT7, STS, TST ALDH1A1 1438/4885HTT 314/4885MMP2 2592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.